Skip to main content

Table 2 Comparison of demographics and comorbidities of patients with lung cancers receiving surgical resection by VATS and thoracotomy

From: Is incentive spirometry beneficial for patients with lung cancer receiving video-assisted thoracic surgery?

 

VATS N = 1404

 

Thoracotomy N = 6145

 

IS

N = 745 (53.1%)

Non-IS

N = 659 (46.9%)

 

IS

N = 4205 (68.4%)

Non-IS

N = 1940 (31.6%)

 

n

%

n

%

p-value

n

%

n

%

p-value

Sex

    

0.44

    

0.35

 Female

384

51.5

326

49.5

 

1599

38.0

762

39.3

 

 Male

361

48.5

333

50.5

 

2606

62.0

1178

60.7

 

Mean age, year (SD)

63.1

(11.7)

62.3

(11.7)

0.16

63.2

(11.1)

63.4

(11.3)

0.63

 < 55

207

27.8

167

25.3

0.52

999

23.8

461

23.8

0.96

 55–64

206

27.7

181

27.5

 

1147

27.3

517

26.7

 

 65–74

235

31.5

209

31.7

 

1462

34.8

681

35.1

 

 75+

97

13.0

102

15.5

 

597

14.2

281

14.5

 

Comorbidity

 COPD

389

52.2

365

55.4

0.23

2435

57.9

1151

59.3

0.29

 Asthma

136

18.3

102

15.5

0.17

604

14.4

318

16.4

0.04

 Other cancer

96

12.9

79

12.0

0.61

313

7.44

148

7.63

0.80

 Heart failure

45

6.04

40

6.04

0.98

166

3.95

83

4.28

0.54

 Neoadjuvant

453

60.8

386

58.6

0.39

2896

68.9

1269

65.4

0.007

 Procedure method

    

0.58

    

0.66

 Pneumonectomy

5

0.67

2

0.30

 

3

0.07

1

0.05

 

 Lobectomy

428

57.5

388

58.9

 

4199

99.9

1936

99.8

 

 Limited resection

312

41.9

269

40.8

 

3

0.07

3

0.15

 
  1. Chi-square test, Fisher’s exact test and Student t test; IS incentive spirometry